Edwards v. CoreValve
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences files transcatheter heart valve patent suit against competitor CoreValve in the District Court of Dusseldorf, Germany May 10. Edwards, developer of the Sapien transcatheter aortic valve, says it has an exclusive sublicense to the patent in question from Johnson & Johnson/Heartport. Edwards, which anticipates European commercialization of Sapien by year-end, is discussing a possible licensing arrangement with CoreValve, which had hoped to launch its ReValving transcatheter aortic valve in Europe in early 2007. Edwards recently received FDA go-ahead to begin a trial to support approval of its device in the United States (1"The Gray Sheet" March 26, 2007, p. 10)...